Lilly To Buy Migraine-drug Maker For $960 Million

vic.ryckaert@indystar.com, Indianapolis Star: Local
Wed, 01/18/2017 - 6:28am

Eli Lilly and Co. will buy migraine-medicine maker CoLucid Pharmaceuticals for $960 million, both companies said in a news release Wednesday.

Sections: u.s.

Salem-Keizer Public Schools crosswalk, bus route testing begins
Salem is testing school zone flashing beacons within the Salem-Keizer Public Schools district and school buses will be doing test runs. More
Explore Oregon Podcast: Three Creek Lake's glory and a new trails plan for Sisters
Host Zach Urness talks to Sisters district ranger Ian Reid about Three Creek Lake and plans for new trails near this Central Oregon town. More
Oregon Ducks inside linebacker Jeffrey Bassa on preparing for Portland State, 2023 season
Oregon Ducks inside linebacker Jeffrey Bassa discusses preparing for the season and game one against Portland State on Saturday at Autzen Stadium. More
Freshman Dillon Thieneman carves starting role for Purdue football
The brother of two former Boilermakers will start against Fresno State as a true freshman. More
'That's why we play tough opponents.' Lafayette Jeff football vows improvement of 0-2 start
The Bronchos host Tech on Friday. More

BING NEWS:

Eli Lilly strikes deal with Amazon Pharmacy for home delivery of Zepbound, other drugs
In addition to Zepbound, the platform offers insulins such as Humalog and Humulin and migraine drug Emgality. Truepill, which operates mail-order pharmacies, is also a dispensing partner for ...
03/13/2024 - 2:48 am | View Link
More

MoviesWithButter : Our Sister Site